44 related articles for article (PubMed ID: 3181182)
1. Nothing but NET: a review of norepinephrine transporter expression and efficacy of 131I-mIBG therapy.
Streby KA; Shah N; Ranalli MA; Kunkler A; Cripe TP
Pediatr Blood Cancer; 2015 Jan; 62(1):5-11. PubMed ID: 25175627
[TBL] [Abstract][Full Text] [Related]
2. Is Overexpression of the Plasma Membrane Transporter (
Evers R
J Pharmacol Exp Ther; 2023 Dec; 387(3):236-238. PubMed ID: 37967896
[No Abstract] [Full Text] [Related]
3. Milestones in dosimetry for nuclear medicine therapy.
Gear J
Br J Radiol; 2022 Jul; 95(1135):20220056. PubMed ID: 35451857
[TBL] [Abstract][Full Text] [Related]
4.
Turnock S; Turton DR; Martins CD; Chesler L; Wilson TC; Gouverneur V; Smith G; Kramer-Marek G
Sci Rep; 2020 Dec; 10(1):20918. PubMed ID: 33262374
[TBL] [Abstract][Full Text] [Related]
5. [The aftercare of radiotherapy patients. The Radiation Protection Commission, the Federal Ministry for the Environment, Nature Protection and Reactor Safety].
Herrmann T
Strahlenther Onkol; 1999 Mar; 175(3):89-92. PubMed ID: 10093608
[No Abstract] [Full Text] [Related]
6. The treatment of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine (131I-MIBG): a comprehensive review of 116 reported patients.
Loh KC; Fitzgerald PA; Matthay KK; Yeo PP; Price DC
J Endocrinol Invest; 1997 Dec; 20(11):648-58. PubMed ID: 9492103
[TBL] [Abstract][Full Text] [Related]
7. Targeted radiotherapy for neuroblastoma.
Meller S
Arch Dis Child; 1997 Nov; 77(5):389-91. PubMed ID: 9487957
[No Abstract] [Full Text] [Related]
8. Predictors of toxicity in treating patients with neuroblastoma by radiolabeled metaiodobenzylguanidine.
Sisson JC; Shapiro B; Hutchinson RJ; Carey JE; Zasadny KR; Zempel SA; Normolle DP
Eur J Nucl Med; 1994 Jan; 21(1):46-52. PubMed ID: 8088285
[TBL] [Abstract][Full Text] [Related]
9. Merkel cell carcinoma and iodine-131 metaiodobenzylguanidine scan.
Castagnoli A; Biti G; De Cristofaro MT; Ferri P; Magrini SM; Papi MG; Bianchi S
Eur J Nucl Med; 1992; 19(10):913-6. PubMed ID: 1451708
[TBL] [Abstract][Full Text] [Related]
10. Critical observations on neuroblastoma treatment with 131-I-metaiodobenzylguanidine at diagnosis.
Mastrangelo R; Lasorella A; Iavarone A; Rufini V; Troncone L; Danza F; Riccardi R
Med Pediatr Oncol; 1993; 21(6):411-5. PubMed ID: 8515721
[TBL] [Abstract][Full Text] [Related]
11. Radiolabelled mIBG in the treatment of neuroblastoma.
Gaze MN; Wheldon TE
Eur J Cancer; 1996 Jan; 32A(1):93-6. PubMed ID: 8695251
[No Abstract] [Full Text] [Related]
12. Toxicity from treatment of neuroblastoma with 131I-meta-iodobenzylguanidine.
Sisson JC; Hutchinson RJ; Carey JE; Shapiro B; Johnson JW; Mallette SA; Wieland DM
Eur J Nucl Med; 1988; 14(7-8):337-40. PubMed ID: 3181182
[TBL] [Abstract][Full Text] [Related]
13. Iodine-125-MIBG to treat neuroblastoma: preliminary report.
Sisson JC; Hutchinson RJ; Shapiro B; Zasadny KR; Normolle D; Wieland DM; Wahl RL; Singer DA; Mallette SA; Mudgett EE
J Nucl Med; 1990 Sep; 31(9):1479-85. PubMed ID: 2395016
[TBL] [Abstract][Full Text] [Related]
14. Treatment of neuroblastoma with [125I]metaiodobenzylguanidine.
Sisson JC; Shapiro B; Hutchinson RJ; Zasadny KR; Mallette S; Mudgett EE; Wieland DM
J Nucl Biol Med (1991); 1991; 35(4):255-9. PubMed ID: 1823830
[TBL] [Abstract][Full Text] [Related]
15. Radiation dosimetry for 131I-mIBG therapy of neuroblastoma.
Flower MA; Fielding SL
Phys Med Biol; 1996 Oct; 41(10):1933-40. PubMed ID: 8912372
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
